This is a preview of subscription content, log in via an institution to check access.
Reference
Park SK, et al. Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standards of Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea. Clinical Therapeutics : 14 May 2019. Available from: URL: http://dx.doi.org/10.1016/j.clinthera.2019.04.031
Rights and permissions
About this article
Cite this article
Combination's cost implications for heart failure in South Korea. PharmacoEcon Outcomes News 830, 9 (2019). https://doi.org/10.1007/s40274-019-5960-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5960-0